These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26508726)

  • 21. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
    Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Gender on the Risk of Neurologic Events and Subsequent Outcomes in Patients With Left Ventricular Assist Devices.
    Sherazi S; Kutyifa V; McNitt S; Papernov A; Hallinan W; Chen L; Storozynsky E; Johnson BA; Strawderman RL; Massey HT; Zareba W; Alexis JD
    Am J Cardiol; 2017 Jan; 119(2):297-301. PubMed ID: 27839770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy.
    Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are blood stream infections associated with an increased risk of hemorrhagic stroke in patients with a left ventricular assist device?
    Aggarwal A; Gupta A; Kumar S; Baumblatt JA; Pauwaa S; Gallagher C; Treitman A; Pappas P; Tatooles A; Bhat G
    ASAIO J; 2012; 58(5):509-13. PubMed ID: 22820918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device.
    Slaughter MS; Sobieski MA; Gallagher C; Dia M; Silver MA
    Tex Heart Inst J; 2008; 35(3):245-9. PubMed ID: 18941649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies.
    Teuteberg JJ; Slaughter MS; Rogers JG; McGee EC; Pagani FD; Gordon R; Rame E; Acker M; Kormos RL; Salerno C; Schleeter TP; Goldstein DJ; Shin J; Starling RC; Wozniak T; Malik AS; Silvestry S; Ewald GA; Jorde UP; Naka Y; Birks E; Najarian KB; Hathaway DR; Aaronson KD;
    JACC Heart Fail; 2015 Oct; 3(10):818-28. PubMed ID: 26450000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD.
    Lalonde SD; Alba AC; Rigobon A; Ross HJ; Delgado DH; Billia F; McDonald M; Cusimano RJ; Yau TM; Rao V
    J Card Surg; 2013 Sep; 28(5):604-10. PubMed ID: 23844652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes after implantation of 139 full-support continuous-flow left ventricular assist devices as a bridge to transplantation.
    Sabashnikov A; Mohite PN; Weymann A; Patil NP; Hedger M; Sáez DG; Zych B; Wahlers T; Wippermann J; De Robertis F; Bahrami T; Amrani M; Simon AR; Popov AF
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):e59-66. PubMed ID: 25180072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of stroke early after implantation of a left ventricular assist device.
    Samura T; Yoshioka D; Toda K; Sakaniwa R; Shimizu M; Miyagawa S; Yoshikawa Y; Hata H; Saito S; Sakata Y; Sawa Y
    J Thorac Cardiovasc Surg; 2019 Jan; 157(1):259-267.e1. PubMed ID: 30060931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late-onset right ventricular dysfunction after mechanical support by a continuous-flow left ventricular assist device.
    Kapelios CJ; Charitos C; Kaldara E; Malliaras K; Nana E; Pantsios C; Repasos E; Tsamatsoulis M; Toumanidis S; Nanas JN
    J Heart Lung Transplant; 2015 Dec; 34(12):1604-10. PubMed ID: 26163154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.
    Topilsky Y; Hasin T; Oh JK; Borgeson DD; Boilson BA; Schirger JA; Clavell AL; Frantz RP; Tsutsui R; Liu M; Maltais S; Kushwaha SS; Pereira NL; Park SJ
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):648-61. PubMed ID: 21940507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.
    Salerno CT; Sundareswaran KS; Schleeter TP; Moanie SL; Farrar DJ; Walsh MN
    J Heart Lung Transplant; 2014 Aug; 33(8):809-15. PubMed ID: 24735680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation.
    Borgi J; Tsiouris A; Hodari A; Cogan CM; Paone G; Morgan JA
    Ann Thorac Surg; 2013 Jan; 95(1):163-9. PubMed ID: 23103012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke after implantation of continuous flow left ventricular assist devices.
    Tsiouris A; Heliopoulos I; Mikroulis D; Mitsias PD
    J Card Surg; 2019 Jul; 34(7):541-548. PubMed ID: 31111542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures.
    Milano C; Pagani FD; Slaughter MS; Pham DT; Hathaway DR; Jacoski MV; Najarian KB; Aaronson KD;
    Circulation; 2014 Sep; 130(11 Suppl 1):S3-11. PubMed ID: 25200052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.